Hepatocellular carcinoma in HIV hepatitis C virus

Current Opinion in HIV and AIDS

Volumn 6, Issue 6, 2011, Pages 534-538

  Puoti, Massimo ^a   Rossotti, Roberto ^a   Garlaschelli, Annalisa ^a   Bruno, Raffaele ^b  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

cirrhosis; hepatitis C virus; hepatocellular carcinoma; HIV; sorafenib; transplantation

Indexed keywords

PEGINTERFERON ALPHA2A PLUS RIBAVIRIN; SORAFENIB;

CANCER INCIDENCE; CANCER PREVENTION; CANCER SCREENING; CANCER SURVIVAL; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CHEMOEMBOLIZATION; DISEASE COURSE; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MIXED INFECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRAL CLEARANCE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CARCINOMA, HEPATOCELLULAR; COINFECTION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; RISK FACTORS;

EID: 80054886533     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e32834bd2b7     Document Type: Review

References (34)

1. Ruppik M, Ledergerber B, Rickenbach M, et al. Changing patterns of causes of death in the SHCS 2005-2009. CROI 2011. Poster # 789. http://www. retroconference.org/2011/PDFs/789.pdf.
2. Sulkowski M. Hepatocellular carcinoma in HIv-infected patients comes of age: the convergence of epidemiology and treatment effectiveness. J Hepatol 2009; 50:655-658.
3. Loko MA, Salmon D, Carrieri P, et al. The French national prospective cohort of patients co-infected with HIv and HCv (ANRS CO13 HEPAvIH): early findings, 2006-2010. BMC Infect Dis 2010; 10:303.
4. Phillips AA, Justmann JE. Screening HIv-infected patients for non-AIDSdefining malignancies. Curr HIv/AIDS Rep 2009; 6:83-92.
5. Salmon-Ceron D, Rosenthal E, Lewden C, et al. Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIv-infected patients: the French national Mortalité2005 study. J Hepatol 2009; 50:736-745.
6. Ocama P, Nambooze S, Opio CK, et al. Trends in the incidence of primary Liver cancer in Central Uganda, 1960-1980 and 1991-2005. Br J Cancer 2009; 100:799-802.
7. Williams JH, Grubb JA, Davis JW, et al. HIv and hepatocellular and esophageal carcinomas related to consumption of mycotoxin-prone foods in sub- Saharan Africa. Am J Clin Nutr 2010; 92:154-160.
8. Petoumenos K, Hui E, Kumarasamy N, et al. TREAT Asia HIv Observational Database. Cancers in the TREAT Asia HIv Observational Database (TAHOD): a retrospective analysis of risk factors. J Int AIDS Soc 2010; 13:51.
9. venkataramani M, Hutton N, Colombani P, et al. Hepatocellular carcinoma in a teenager with perinatally acquired HIv Infection without hepatitis B or C coinfection: a case report. AIDS Patient Care STDS 2010; 24:693-696.
10. Bruno R, Puoti M, Sacchi P, et al. Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients. J Hepatol 2006; 44 (1 Suppl):S146-S150. (Pubitemid 43053891)
11. Bruno R, Galastri S, Sacchi P, et al. F. gp120 modulates the biology of human hepatic stellate cells: a link between HIv infection and Liver fibrogenesis. Gut 2010; 59:513-520.
12. Clifford GM, Rickenbach M, Polesel J, et al. Influence of HIv-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS 2008; 22:2135-2141.
13. Berenguer J, Alvarez-Pellicer J, Martín PM, et al. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2009; 50:407-413.
14. M Sulkowski, D Dieterich, K Sherman M, et al. Interim analysis of a phase 2a double-blind study of TvR in combination with pegIFN-a2a and RBv in HIv/ HCv co-infected patients. 18th Conference on Retroviruses and Opportunistic Infections. Boston. 27 February-2 March 2011.
15. Bräu N, Fox RK, Xiao P, et al. Presentation and outcome of hepatocellular carcinoma in HIv-infected patients: a U.S.-Canadian multicenter study. J Hepatol 2007; 47:527-537. (Pubitemid 47334759)
16. Bräu N, Kikuchi L, Núñez M, et al. Liver Cancer in HIv Study Group. Improved survival of hepatocellular carcinoma (HCC) in HIv infected patients with undetectable HIvRNA. 45th Annual Meeting of the European Association for the Study of the Liver; 14-18 April 2010; vienna, Austria. Poster no. 548.
17. Garlassi E, ventura P, Beretta M, et al. Hepatocellular carcinoma in HIv infected patients: check early, treat hard. Infection 2010; 38 (Suppl I):82-182.
18. Nunez M, Kikuchi L, Barreiro P, et al. Screening for hepatocellular carcinoma (HCC) in HIv/HCv-co-infected patients: impact on staging, therapy, and survival. Presented at the 17th Conference on Retroviruses and Opportunistic Infections, San Francisco CA, 16-19 February 2010. Abstract No. 685 2010.
19. Phillips AA, Justman JE. Screening HIv-infected patients for non-AIDS-defining malignancies. Curr HIv/AIDS Rep 2009; 6:83-92.
20. Joshi D, O'Grady J, Dieterich D, et al. Increasing burden of Liver disease in patients with HIv infection. Lancet 2011; 377:1198-1209.
21. Prestini K, Biasi L, Mendeni M, et al. Incidence and predictors of hepato cellular carcinoma (HCC) in cirrhotics living with HIv [abstract]. 5th International HIv and Hepatitis Workshop, 4th-6th June 2009; Lisbon, Portugal.
22. Rockstroh JK, Bhagani S, Benhamou Y, et al., EACS Executive Committee.. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIv-infected adults. HIv Med 2008; 9:82-88. (Pubitemid 351228130)
23. Kelleher TB, Afdhal N. Assessment of Liver fibrosis in co-infected patients. J Hepatol 2006; 44 (1 Suppl):S126-S131. (Pubitemid 43053888)
24. Ozenne v, Gervais A, Peytavin G, et al. Suspected interaction between sorafenib and HAART in an HIv-1 infected patient: a case report. Hepatogastroenterology 2011; 58:161-162.
25. Chelis L, Ntinos N, Souftas v et al. Complete response after sorafenib therapy for hepatocellular carcinoma in an HIv-HBv co infected patient: possible synergy with HAART? A case report. Med Oncol 2010; [Epub ahead of print]. DOI 10.1007/s 12032-010-9669-y
26. Perboni G, Costa P, Fibbia GC, et al. Sorafenib therapy for hepatocellular carcinoma in an HIv-HCv coinfected patient: a case report. Oncologist 2010; 15:142-145.
27. Baraboutis IG, Papastamopoulos v, Charitsis G, et al. First-time use of bevacizumab for aggressive, metastatic hepatocellular carcinoma in an HIv/hepatitis B virus coinfected patient: a case report. Eur J Gastroenterol Hepatol 2008; 20:472-473. (Pubitemid 351533886)
28. Di Benedetto F, Tarantino G, De Ruvo N, et al. University of Modena experience in HIv-positive patients undergoing Liver transplantation. Transplant Proc 2011; 43:1114-1118.
29. Vibert E, Duclos-Vallée JC, Ghigna MR, et al. Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infection. Hepatology 2011; 53:475-482.
30. Murillas J, Rimola A, Laguno M, et al., ESLD-HIV Working Group Investigators.The model for end-stage Liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage Liver disease: a prospective cohort study. Liver Transpl 2009; 15:1133-1141.
31. Baccarani U, Adani GL, Bragantini F, et al. Long-term outcomes of orthotopic Liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases. Transplant Proc 2011; 43:1119-1122.
32. Di Benedetto F, Di Sandro S, De Ruvo N, et al. First report on a series of HIv patients undergoing rapamycin monotherapy after Liver transplantation. Transplantation 2010; 89:733-738.
33. Cooper C, Kanters S, Klein M, et al. Liver transplant outcomes in HIv-infected patients: a systematic review and meta-analysis with synthetic cohort. AIDS 2011; 25:777-778.
34. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2010 (in press). http://www.aasld.org/practiceguidelines/Documents/ Bookmarked%20Practice%20Guidelines/HCCUpdate2010.pdf